ONCXERNA THERAPEUTICS

Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Apr 2024)

What this means for you

This application is over — abandoned 15 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90109938
Mark type
Stylized text
Filed
12 Aug 2020
Published for opposition
20 Jul 2021
Abandoned
15 Apr 2024
Attorney of record
Monica Riva Talley

Goods and services

  • Class 001 — Chemicals: Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, cultures of microorganisms, protein-based capsids and particles as well as fragments, fractions and derivatives thereof, for scientific and medical research; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs; protein arrays for diagnosing cancer
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, preparations containing proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use, namely, tumor markers; antigens for medical purposes; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use
  • Class 042 — Scientific and technological services: Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; bioinformatics, chemical and biological analysis

Owner

Prosecution history

  • 15 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 15 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
  • 16 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 14 Sept 2023 — SOU EXTENSION 4 GRANTED
  • 14 Sept 2023 — SOU EXTENSION 4 FILED
  • 14 Sept 2023 — SOU TEAS EXTENSION RECEIVED
  • 24 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 22 Feb 2023 — SOU EXTENSION 3 GRANTED
  • 22 Feb 2023 — SOU EXTENSION 3 FILED
  • 22 Feb 2023 — SOU TEAS EXTENSION RECEIVED
  • 09 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 07 Sept 2022 — SOU EXTENSION 2 GRANTED
  • 07 Sept 2022 — SOU EXTENSION 2 FILED
  • 07 Sept 2022 — SOU TEAS EXTENSION RECEIVED
  • 29 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

View this trademark record on Marksy